Skip to content
Sexuality – Lifestyle
Author:
IGI, Inc.
Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors
May 20, 2026